Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Hendlisz

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
Expert Review of Anticancer Therapy|January 30, 2004
New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspectiveAhmad Awada, Max Mano, Alain Hendlisz, et al.
Current Opinion in Oncology|June 3, 2026
From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancersAlain Hendlisz, Leila Shaza, Thierry De Grez, et al.
Current Opinion in Oncology|April 21, 2021
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trialsEmilio Francesco Giunta, Giacomo Bregni, Alain Hendlisz, et al.
Clinical Nuclear Medicine|May 16, 2018
Acute Pancreatitis Following Peptide Receptor Radionuclide Therapy: An Unusual Adverse EventIoannis Karfis, Gwennaëlle Marin, Godelieve Machiels, et al.
World Journal of Gastroenterology|April 22, 2016
Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastasesValerio Lucidi, Alain Hendlisz, Jean-Luc Van Laethem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2022
JCOG0603: Are We Really Sure This Was a Negative Trial?Rita Saude Conde, Giacomo Bregni, Everardo Saad, et al.
Current Opinion in Oncology|June 22, 2022
Mind the target: human epidermal growth factor receptor 2 in colorectal cancerRita Saúde-Conde, Gertjan Rasschaert, Giacomo Bregni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Progression-free survival ratio as end point for phase II trials in advanced solid tumorsMarc Buyse, Emmanuel Quinaux, Alain Hendlisz, et al.
Cancer Treatment Reviews|December 31, 2023
Neoadjuvant chemotherapy for early-stage colon cancerAlessandro Audisio, Roberta Fazio, Valentina Daprà, et al.
Cancer Letters|November 1, 2019
PD-1 and PD-L1 inhibitors in oesophago-gastric cancersTugba Akin Telli, Giacomo Bregni, Silvia Camera, et al.
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
Expert Review of Anticancer Therapy|January 30, 2004
New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspectiveAhmad Awada, Max Mano, Alain Hendlisz, et al.
Current Opinion in Oncology|June 3, 2026
From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancersAlain Hendlisz, Leila Shaza, Thierry De Grez, et al.
Current Opinion in Oncology|April 21, 2021
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trialsEmilio Francesco Giunta, Giacomo Bregni, Alain Hendlisz, et al.
Clinical Nuclear Medicine|May 16, 2018
Acute Pancreatitis Following Peptide Receptor Radionuclide Therapy: An Unusual Adverse EventIoannis Karfis, Gwennaëlle Marin, Godelieve Machiels, et al.
World Journal of Gastroenterology|April 22, 2016
Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastasesValerio Lucidi, Alain Hendlisz, Jean-Luc Van Laethem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2022
JCOG0603: Are We Really Sure This Was a Negative Trial?Rita Saude Conde, Giacomo Bregni, Everardo Saad, et al.
Current Opinion in Oncology|June 22, 2022
Mind the target: human epidermal growth factor receptor 2 in colorectal cancerRita Saúde-Conde, Gertjan Rasschaert, Giacomo Bregni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2011
Progression-free survival ratio as end point for phase II trials in advanced solid tumorsMarc Buyse, Emmanuel Quinaux, Alain Hendlisz, et al.
Cancer Treatment Reviews|December 31, 2023
Neoadjuvant chemotherapy for early-stage colon cancerAlessandro Audisio, Roberta Fazio, Valentina Daprà, et al.
Cancer Letters|November 1, 2019
PD-1 and PD-L1 inhibitors in oesophago-gastric cancersTugba Akin Telli, Giacomo Bregni, Silvia Camera, et al.
Pageof 14